| Literature DB >> 28224016 |
Jun Lei1, Ying Xue2, Yi-Ming Liu3, Xun Liao3.
Abstract
The peels of citrus fruits (Pericarpium Citri Reticulatae, PCR) have long been used in traditional Chinese medicines (TCMs). Polymethoxylated flavonoids (PMFs) were found to be the main components present in PCR extracts, but their metabolism remains unclear which restrain the utilization of this TCM. In the present work, rat liver microsomes were immobilized on magnetic nanoparticles (LMMNPs) for in vitro metabolic study on the whole PMFs of PCR. LMMNPs were characterized by transmission electron microscope and Fourier-transform infrared spectrum. The relative enzyme binding capacity of LMMNPs was estimated to be about 428 μg/mg from thermogravimetric analysis. Incubation of LMMNPs with PMFs produced demethylated metabolites of PMFs, six of which were identified by ultrahigh pressure liquid chromatography-mass spectrometry (UPLC-MS/MS). The 3'-hydroxylated tangeretin (T3) was detected from the metabolites of tangeretin for the first time, which suggested that 4'-demethylated and 3'-hydroxylated derivative of tangeretin (3'-hydroxy-5,6,7,8,4'-pentamethoxyflavone, T4) was not only derived from 4'-demethylated tangeretin (T2) as previously reported, but also from T3. This is the first investigation of the metabolism of the whole PMFs, which may shed light on the mechanism of action of PCR.Entities:
Keywords: Liver microsome; Magnetic nanoparticles; Metabolism; Pericarpium Citri Reticulatae; Polymethoxylated flavonoids
Year: 2017 PMID: 28224016 PMCID: PMC5293709 DOI: 10.1186/s13065-017-0237-9
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Fig. 1TEM images of a Fe3O4@SiO2 magnetic nanoparticles and b LMMNP nanoparticle bioreactors
Fig. 2TGA analysis of (A) Fe3O4@SiO2, (B) Fe3O4@SiO2@PDDA and (C) LMMNPs
K m and V max for free and immoblized rat liver microsomes for PNP
| Form of microsomes |
|
|
|---|---|---|
| Free microsomes | 0.15 | 200 |
| LMMNPs | 0.45 |
Fig. 3The UPLC analysis of the whole extract of PCR incubation solution a 0 min; and b 60 mmin. Compounds represented by peaks 3–12 are listed in Table 2
The compounds identified in incubation solutions at 0 min (M0) and 60 min (M1), respectively
| Peaks |
| M0 [M+H]+ | M1 [M+H]+ | MS2 | Identification |
|---|---|---|---|---|---|
| 1 | 2.59 | – | 375 | 345 | Di hydroxy tetramethoxyflavone |
| 2 | 2.63 | – | 375 | 345 | Di hydroxy tetramethoxyflavone |
| 3 | 2.81 | – | 375 | 345, 331, 301 | 3′,4′-di hydroxy-5,6,7,8- tetramethoxy-flavone |
| 4 | 3.16 | – | 389 | 359, 374, 341 | 6-hydroxy-5,7,8,3′,4′-pentamethoxy-flavone or 7-hydroxy-5,6,8,3′,4′-pentame-thoxyflavone |
| 6 | 3.25 | – | 359 | 329 | 4′-hydroxy-5,6,7,8- tetramethoxyflavone |
| 7 | 3.33 | 389 | 389 | 359, 374, 341 | 4′-hydroxy - 5,6,7,8,3′-pentamethoxyfla-vone or 3′-hydroxy- 5,6,7,8,4′-pentame-thoxyflavone |
| 8 | 3.53 | 373 | 373 | 343, 312 | Pentamethoxyflavone |
| 9 | 3.60 | 359 | 359 | 329 | Monohydroxy-tetramethoxyflavone |
| 10 | 3.88 | 403 | 403 | 373 | Nobiletin |
| 11 | 4.25 | 373 | 373 | 343, 325 | Tangeritin |
| 12 | 4.53 | 389 | 389 | 359, 341, 374 | Monohydryoxy- pentamethoxyflavone |
Fig. 4The UPLC chromatograms of tangeretin and nobiletin solutions incubated with LMMNPs: a tangeretin + LMMNPs at 0 min; b tangeretin + LMMNPs at 60 min; c nobiletin + LMMNPs at 0 min; and d nobiletin + LMMNPs at 60 min
Fig. 5UPLC–MS chromatograms from the incubation solution at 60 min. a Tangeretin; b nobiletin
Fig. 6The proposed metabolic pathways of tangeretin (a) and nobiletin (b)